Clinical Trials Browser

Prostatic Neoplasms, Castration-Resistant × abiraterone × Clear all

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT05551117 2026-02-09

Tamarack

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT04844749 2024-02-05

VERACITY

Phase 3 Terminated

105 enrolled

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT03173859 2020-11-18

AERA

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT02254785 2017-12-06

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Phase 2 Unknown

120 enrolled

Genitourinary

Prostatic Neoplasms, Castration-Resistant

Clinical Trials

IDeate-Prostate02

Tamarack

VERACITY

AERA

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer